Literature DB >> 2828685

Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells.

J N Glickman1, J G Howe, J A Steitz.   

Abstract

The ribonucleoprotein (RNP) particles containing the Epstein-Barr virus-associated small RNAs EBER1 and EBER2 were analyzed to determine their RNA secondary structures and sites of RNA-protein interaction. The secondary structures were probed with nucleases and by chemical modification with single-strand-specific reagents, and the sites of modification or cleavage were mapped by primer extension. These data were used to develop secondary structures for the two RNAs, and likely sites of close RNA-protein contact were identified by comparing modification patterns for naked RNA and RNA in RNP particles. In addition, sites of interaction between each Epstein-Barr virus-encoded RNA (EBER) and the La antigen were identified by analyzing RNA fragments resistant to digestion by RNase A or T1 after immunoprecipitation by an anti-La serum sample from a lupus patient. Our results confirm earlier findings that the La protein binds to the 3' terminus of each molecule. Possible functions for the EBER RNPs are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828685      PMCID: PMC253649          DOI: 10.1128/JVI.62.3.902-911.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Interferon, double-stranded RNA, and protein phosphorylation. Characteristics of a double-stranded RNA-activated protein kinase system partially purified from interferon treated Ehrlich ascites tumor cells.

Authors:  G C Sen; H Taira; P Lengyel
Journal:  J Biol Chem       Date:  1978-09-10       Impact factor: 5.157

2.  Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII.

Authors:  M D Rosa; E Gottlieb; M R Lerner; J A Steitz
Journal:  Mol Cell Biol       Date:  1981-09       Impact factor: 4.272

3.  Estimation of secondary structure in ribonucleic acids.

Authors:  I Tinoco; O C Uhlenbeck; M D Levine
Journal:  Nature       Date:  1971-04-09       Impact factor: 49.962

4.  Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information.

Authors:  M Zuker; P Stiegler
Journal:  Nucleic Acids Res       Date:  1981-01-10       Impact factor: 16.971

5.  The conformation of adenovirus VAI-RNA in solution.

Authors:  H J Monstein; L Philipson
Journal:  Nucleic Acids Res       Date:  1981-09-11       Impact factor: 16.971

6.  Partial digestion of tRNA--aminoacyl-tRNA synthetase complexes with cobra venom ribonuclease.

Authors:  O O Favorova; F Fasiolo; G Keith; S K Vassilenko; J P Ebel
Journal:  Biochemistry       Date:  1981-02-17       Impact factor: 3.162

7.  Structure of genes for virus-associated RNAI and RNAII of adenovirus type 2.

Authors:  G Akusjärvi; M B Mathews; P Andersson; B Vennström; U Pettersson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

8.  A new species of virus-coded low molecular weight RNA from cells infected with adenovirus type 2.

Authors:  H Söderlund; U Pettersson; B Vennström; L Philipson; M B Mathews
Journal:  Cell       Date:  1976-04       Impact factor: 41.582

9.  Mapping adenines, guanines, and pyrimidines in RNA.

Authors:  H Donis-Keller; A M Maxam; W Gilbert
Journal:  Nucleic Acids Res       Date:  1977-08       Impact factor: 16.971

10.  Precursor molecules of both human 5S ribosomal RNA and transfer RNAs are bound by a cellular protein reactive with anti-La lupus antibodies.

Authors:  J Rinke; J A Steitz
Journal:  Cell       Date:  1982-05       Impact factor: 41.582

View more
  79 in total

1.  Straightening of bulged RNA by the double-stranded RNA-binding domain from the protein kinase PKR.

Authors:  X Zheng; P C Bevilacqua
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis.

Authors:  I K Ruf; P W Rhyne; C Yang; J L Cleveland; J T Sample
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Efficient transcription of the EBER2 gene depends on the structural integrity of the RNA.

Authors:  Edda Dümpelmann; Hendrik Mittendorf; Bernd-Joachim Benecke
Journal:  RNA       Date:  2003-04       Impact factor: 4.942

4.  The binding site of the RNA-dependent protein kinase (PKR) on EBER1 RNA from Epstein-Barr virus.

Authors:  Momchilo Vuyisich; Richard J Spanggord; Peter A Beal
Journal:  EMBO Rep       Date:  2002-07       Impact factor: 8.807

5.  EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN.

Authors:  Mrinal Samanta; Dai Iwakiri; Teru Kanda; Tadaatsu Imaizumi; Kenzo Takada
Journal:  EMBO J       Date:  2006-08-31       Impact factor: 11.598

6.  Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study.

Authors:  L M Weiss; Y Y Chen; X F Liu; D Shibata
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

7.  Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI.

Authors:  P A Clarke; M Schwemmle; J Schickinger; K Hilse; M J Clemens
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

8.  Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens.

Authors:  T C Wu; R B Mann; J I Epstein; E MacMahon; W A Lee; P Charache; S D Hayward; R J Kurman; G S Hayward; R F Ambinder
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

Review 9.  Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis.

Authors:  Javier S Burgos
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

10.  Detection of Eber-1 RNA in primary brain lymphomas in immunocompetent and immunocompromised patients.

Authors:  R Bashir; B McManus; C Cunningham; D Weisenburger; F Hochberg
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.